SCHEMBL17830430

SCHEMBL17830430

CNS(=O)(=O)c1cc(NC(C)=O)ccc1/C=C/c1ccc(N)cc1[SH](=O)=O

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ENPP2 Q13822 1/20 0.51
RAD51 Q06609 3/20 0.43
PKM P14618 1/20 0.40
CYP2C19 P33261 1/20 0.40
ALDH1A1 P00352 2/20 0.39
APEX1 P27695 1/20 0.39
GSTO1 P78417 1/20 0.37
CLK1 P49759 1/20 0.36
LDHA P00338 1/20 0.36
MEN1 O00255 2/20 0.35
MAPT P10636 2/20 0.35
KMT2A Q03164 2/20 0.35
PIK3C3 Q8NEB9 1/20 0.35
GAA P10253 1/20 0.35
KDM4E B2RXH2 2/20 0.34
NPC1 O15118 1/20 0.34
PABPC1 P11940 1/20 0.34
RAB9A P51151 1/20 0.34
CDK1 P06493 1/20 0.34
ATAD2 Q6PL18 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17830432 0.85 ENPP2 (0.68) ENPP2RAD51ALDH1A1APEX1GSTO1
SCHEMBL19726901 0.79 ENPP2 (0.60) ENPP2RAD51PKMALDH1A1APEX1
SCHEMBL7825431 0.78 ENPP2 (0.78) ENPP2RAD51PKMCYP2C19ALDH1A1
SCHEMBL7550076 0.78 ENPP2 (0.78) ENPP2RAD51PKMCYP2C19ALDH1A1
SCHEMBL19726891 0.74 ENPP2 (0.44) ENPP2RAD51PKMALDH1A1APEX1
SCHEMBL19726905 0.74 ENPP2 (0.46) ENPP2RAD51PKMALDH1A1APEX1
SCHEMBL19733689 0.73 ENPP2 (0.53) ENPP2RAD51ALDH1A1APEX1GSTO1
SCHEMBL17830249 0.73 ENPP2 (0.53) ENPP2RAD51PKMALDH1A1APEX1
SCHEMBL19713037 0.73 ENPP2 (0.53) ENPP2RAD51PKMALDH1A1APEX1
SCHEMBL9321055 0.71 ENPP2 (0.91) ENPP2RAD51ALDH1A1APEX1LDHA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016094897-A1 COMPOSITIONS AND METHODS RELATING TO THE TREATMENT OF CANCER, AUTOIMMUNE DISEASE, AND NEURODEGENERATIVE DISEASE THE JACKSON LABORATORY (US) 2016-06-16 WO disclosed